IvanRychlik Czech RepublicCharles University, Third Faculty of Medicine, Department of Internal Medicine

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Hands on Big Data Mining for the Nephrologist in 2024 SK1001 HeatherAscani Chairperson United StatesUniversity of Michigan KatherineTuttle Chairperson United StatesUniversity of Washington School of Medicine, Division of Nephrology MatthiasKretzler Chairperson United StatesUniversity of Michigan Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse VijiNair Speaker United StatesUniversity of Michigan Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI MatthiasKretzler Speaker United StatesUniversity of Michigan The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University Panel Discussion Hall C1	Population Health and Strategies to Protect the Fragile BKH01 EnriqueDorado Chairperson egdorado@gmail.comArgentinaInstituto de Investigaciones Médicas "A. Lanari". Universidad de Buenos Aires ShokoufehSavaj Chairperson Iran Being Born Too Small: What a Nephrologist Should Know to Support Prevention of CKD in Future Generations DanieleTrevisanuto Speaker daniele.trevisanuto@unipd.itItalyUniversity Hospital of Padova, Italy Hypertensive Disorders of Pregnancy as a Means to Discover CKD Giorgina BarbaraPiccoli Speaker FranceCentre Hospitalier Le Mans Managing Pregnancy with Advanced CKD in a Limited-resource Setting AlejandraOrozco Guillen Speaker ale_gaba@hotmail.comMexicoNational Institute of Perinatology, Nephrology dep Pre-eclampsia and its Differential Diagnosis: A Viewpoint from LMICs RashaShemies Speaker rashasamirtaha@gmail.comEgyptMansoura University Q and A Hall D
2:45 p.m. 3:30 p.m.	What is ongoing in CKDu around the world? - CKDU interactive discussions (ISN i3C) SPOT-06 ErangaWijewickrama Spotlight Chairperson Sri LankaFaculty of Medicine, University of Colombo Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) Magdalena Madero Spotlight Speaker MexicoChief of Nephrology, Instituto Nacional de Cardiol VivekanandJha Spotlight Speaker IndiaGeorge Institute for Global Health India NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka Spotlight Stage 1 (exhibition hall)
4 p.m. 4:30 p.m.	Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis SPOT-07 BradRovin Spotlight Speaker United StatesThe Ohio State University UptalPatel Spotlight Speaker United States Spotlight Stage 1 (exhibition hall)
4:30 p.m. 5:30 p.m.	New Developments in CKD Epidemiology Research IK1001 MaartenTaal Chairperson United KingdomUniversity of Nottingham RobertoPecoits Filho Chairperson United StatesArbor Research Collaborative for Health Big Data Lab LAB-01 Patient-reported Outcome Measures: How Do Patients Experience CKD? AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care Trial Simulation Using Observational Data AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgUnited StatesArbor Research Collaborative for Health Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges DorotheaNitsch Speaker United KingdomLondon School of Hygiene & Tropical Medicine Q and A Hall C4

Day 2 - Monday April 15, 2024

Time	Session

11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) PL3 Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) MegJardine Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comIsraelhttps://research.ibm.com/ Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	It WIN AlejandraOrozco Guillen Chairperson ale_gaba@hotmail.comMexicoNational Institute of Perinatology, Nephrology dep IvanRychlik Chairperson ivan.rychlik@fnkv.czCzech RepublicCharles University, Third Faculty of Medicine, Department of Internal Medicine Rita MarcelaFortunato Chairperson marcelafortunator@gmail.comArgentinaFundacion Favaloro University Hospital, Faculty of Medicine, University of Buenos Aires Women and UrmilaAnandh Speaker IndiaAmrita Hospitals, Faridabad, Delhi NCR Pregnancy and CKD LizLightstone Speaker United KingdomImperial College London Pregnancy and Transplantation SilviShah Speaker United StatesUniversity of Cincinnati, Ohio, United States Global and African Epidemiology, Management and Outcomes of CKD and dialysis in Men and Women: A Perspective on Gender Disparities RashaDarwish Speaker EgyptKasr Aleiny medical school , Cairo University Q and A Hall C4
3 p.m. 4 p.m.	Treatment Goals for Severe Hyponatremia: A Debate on Current Guidelines Program LF1005 MitchellRosner Chairperson United StatesUniveristy of Virginia Health Overview of Hyponatremia Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore Pro: Current Guidelines are Appropriate HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUnited StatesUniversity of Pittsburgh School of Medicine Con: Current Guidelines are Too Conservative CarlosAyus Speaker carlosayus@yahoo.comUnited StatesUniversity of California Irvine Discussion Hall C3
4:30 p.m. 5:30 p.m.	Paraproteinemia and the Kidney CHAL05 CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caCanadaUniversité de Montréal Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina MGRS: Should All Forms Need Clonal Therapy? FrankBridoux Speaker f.bridoux@chu-poitiers.frFranceDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, France Renal Amyloidosis: What Is New? Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brBrazilSão Paulo State Cancer Institute - University of São Paulo Can We Perform a Transplant in Patients with Myeloma and Amyloidosis? SabineKaram Speaker United StatesUniversity of Minnesota Q and A Hall A

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10 a.m.	Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment LF1002 DebasishBanerjee Chairperson United KingdomSt George's University Hospital NHS Foundation Tr MegJardine Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Setting the Scene MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia DM and CKD: Which Treatment Should I Use for Different Populations? KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology How to Design Studies on Answering Unanswered Questions VladoPerkovic Speaker AustraliaUniversity of New South Wales, Sydney, Australia The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes DavidWheeler Speaker United KingdomUniversity College London Q and A Hall C4

Time

Session

9 a.m.

10 a.m.

Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment

LF1002

DebasishBanerjee Chairperson United KingdomSt George's University Hospital NHS Foundation Tr

MegJardine Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia

Setting the Scene

MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
DM and CKD: Which Treatment Should I Use for Different Populations?

KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology
How to Design Studies on Answering Unanswered Questions

VladoPerkovic Speaker AustraliaUniversity of New South Wales, Sydney, Australia
The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes

DavidWheeler Speaker United KingdomUniversity College London
Q and A

Hall C4